Grifols

Grifols Net Debt/FCF

The Net Debt to Free Cash Flow Ratio of Grifols (GRF.MC) as of Nov 2, 2026 is 12.45. In the previous year, Net Debt to Free Cash Flow Ratio was 13.62 — a change of -8.55% (lower).

Net Debt/FCF

12.45

YoY

-8.55%

Last updated:

Net Debt to Free Cash Flow Ratio of Grifols is 2025 12.45 . Net Debt to Free Cash Flow Ratio of Grifols was 2024 13.62 . It decreases by -8.55% lower compared to the previous year.

The Grifols Net Debt/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/FCF
Date
Net Debt/FCF
Jan 1, 2018
12.21 EUR
Jan 1, 2019
25.15 EUR
Jan 1, 2020
8.92 EUR
Jan 1, 2021
24.76 EUR
Jan 1, 2022
-26.23 EUR
Jan 1, 2023
-108.70 EUR
Jan 1, 2024
13.62 EUR
Jan 1, 2025
12.45 EUR
The Grifols Net Debt/FCF history
YEARNet Debt/FCFYoY
12.45-8.55%
13.62-112.53%
-108.70+314.47%
-26.23-205.93%
24.76+177.66%
8.92-64.55%
25.15+105.97%
12.21+23.63%
9.88-35.48%
15.31-25.57%
20.57+344.27%
4.63—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Grifols Stock analysis

What does Grifols do? Grifols SA is a globally operating company specialized in the manufacture and marketing of medical products and technologies. The company is headquartered in Barcelona, Spain and has been in existence for over 75 years. Grifols focuses on improving the quality of life through the production and marketing of blood products and services, diagnostics, and hospital pharmaceuticals. It has four main business areas: Bioscience, Hospital, Diagnostic, and Bio Supplies. Grifols emphasizes research and development to meet customer needs. It has introduced various products, including AlfaBIO, Vistogard, ID Core XT, NEO Blood Bank, and MIRASOL Pathogen Reduction Technology. Grifols is committed to innovation and quality, providing products and services that cater to a wide range of customers. Additionally, it is a significant employer in the biotechnology industry and contributes to economic development in different regions. Grifols is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Grifols stock

Net Debt to Free Cash Flow Ratio of Grifols is 12.45 in 2025.

Net Debt to Free Cash Flow Ratio of Grifols changed from 13.62 to 12.45, representing a -8.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio Grifols since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's Grifols with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Grifols

All Key Metrics — Grifols